Tilray Brands, Inc. ("Tilray”) (Nasdaq: TLRY; TSX: TLRY), a leading lifestyle and consumer packaged goods company, is excited ...

It was almost four years ago that Tilray Brands (NASDAQ: TLRY) announced that it would be merging with low-cost cannabis ...

In July 2024, Tilray’s Aphria RX became the first company to receive a cultivation license under MedCanG, allowing them to produce and manufacture medical cannabis for commercial sale in Germany. The ...

Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment ...

Tilray Medical, a division of ("Tilray Brands") (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners ...

Aphria is a leading global cannabis company driven by an unrelenting commitment to our people, the planet, product quality and innovation. Headquartered in Leamington, Ontario – the greenhouse capital ...

Tilray Medical launches its first German-grown cannabis products under a new cultivation license, tapping into Germany's ...

The launch marks the first medical cannabis products Aphria RX has grown under the medical cannabis cultivation license ...

Cannabidiol Market Size Cannabidiol Market is estimated to be valued at USD 8.12 Bn in 2024 and is expected to reach USD 23.41 Bn by 2031, exhibiting a CAGR of 16.3% from 2024 to 2031. BURLINGAME, CA, ...

Medical, a division of Tilray Brands, announced the launch of its first commercial German grown medical cannabis flowers from its ...